Patent · US Active

Compounds

US10590125B2 · kind B2 · utility

1Cited by
4References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2016
Grant dateMar 17, 2020
Priority date
Expiry dateJul 20, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C53/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds which are inhibitors of SSAO activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases, immune disorders and the inhibition of tumor growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.